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Immunologic Response and Factors Affecting
Its Assessment
by John A. Moore' and Robert E. Faith*
The potential harmful effects of toxic compounds on the developing immune system are
discussed. This discussion is illustrated by results of studies on the effects of 2,3,7,8-
tetrachlorodibenzo-p-dioxin on the developing immune system of Fischer rats. While this com-
pound and several others have been shown to have immunosuppressive effects, the available data
do not support routine evaluation of the consequence of chemical exposure to the developing im-
mune system.
Introduction
This presentation strives to establish a
rationale for investigatory research into the
possible deleterious effects ofchemicals or agents
during immune ontogenesis, illustrate the results
of such research, discuss factors which bear on in-
terpretation of such research, and suggest basic
approaches in the design of experiments that
assess effects of chemicals on the developing im-
mune system.
For the purposes of this paper, "immunologic
response" is principally restricted to a response
by those cells in which specific antigen
recognition is inherent, e.g., production of an-
tibody or cell mediated immune responses. We in-
tend to discuss only depression. For clarity and
brevity, cells which perform important but ac-
cessory roles are relegated to a position of benign
neglect (e.g., fixed and free macrophages, mast
cells, and various other leukocytic cell types).
This is a calculated risk, since diminished ac-
cessory cell function may partially mask immune
response given their role in the preparation of an-
tigen for recognition by or presentation to im-
mune competent cells or in the expression of
select immune reactions.
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Need for Research on the Developing Immune
System
Incorporation of tests which evaluate immune
function during toxicologic evaluation of
chemicals has not kept pace with the rapid ad-
vances being made in the field of immunology.
Stimulation of an undesired immune response
(sensitization) has been evaluated to some
degree, but testing for suppressive effects has
been haphazard. Failure to recognize the need for
such procedures is a bit surprising given that
chemicals have been identified and developed
because they possess immunosuppressive proper-
ties. Corticosteroids, azathioprine, cyclophos-
phamide, 6-mercaptopurine, and methotrexate
are chemicals utilized in the treatment of specific
forms of neoplasia or in controlling host rejection
processes during various grafting procedures (1).
There is a select, but important, list of chemicals
not utilized in medical applications that produce a
distinct immunosuppression. These include poly-
chlorinated biphenyls (PCBs) (2-6), organotin
compounds (7), 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) (8-10), lead, and cadmium
(11-14). While not definitive, but clearly germane
to this topic, specific immunodeficiency as a possi-
ble consequence of methylmercury exposure dur-
ing fetal and neonatal development has also been
December 1976 125reported (15). Exposure to corticosteroids during
development also has produced immune deficien-
cies (16).
Development of immune competence is a
process which requires the sequenced migration
of cell types through noncontiguous tissues
during an extended, but temporally ordered
period of fetal/neonatal development (17).
Development failure, delayed maturation or mal-
function of an organ may arrest, delay, or other-
wise compromise development of a specific popu-
lation of immune competent cells (18). The inter-
dependent and temporally sequenced nature of
this process suggests that chemicals which affect,
even in a transient way, adult immune capabili-
ties may produce similar, more profound or per-
manent effects in developing systems.
EffectsofTCDDon Immunity
TCDD is known to induce a pronounced
atrophy ofthymus, spleen, and to a lesser extent,
peripheral lymph nodes of rats, mice, and guinea
pigs (8,19,20). Although there is species variation
in the degree and severity of other organ effects,
the effects of TCDD on lymphoid containing
tissues is consistent in all species. It is also known
to be a teratogen in mice, producing cleft palate
or hydronephrosis (21,22). It is primarily
fetotoxic or lethal in rat teratology studies (23).
Studies of immune function in several species
of animals exposed as adults found cellular im-
mune capabilities to be impaired (8,9). This cir-
cumstance combined with the teratogenic data
that demonstrate the ability of TCDD to gain ac-
cess to the fetus prompted investigation of the
possible effect(s) of TCDD on the developing im-
mune system.
In initial experiments, 1-day-old rat pups from
mothers who had received TCDD on days 11 and
18 of gestation had diminished thymus and spleen
weights; the thymus on histopathologic
examination showed atrophy of the cortex due to
a paucity of lymphoid cells (9). Since a significant
degree of immune maturation occurs during the
nursing period in the rat, experiments were
designed whereby pups were exposed to TCDD
either by treatment of the mother on gestation
day 18 as well as postnatal days 0, 7, and 14 or by
maternal treatment on postnatal days 0, 7, and
14. The Fischer rat litters were standardized at 8
pups per litter at birth. Suppressive effects on
the immune system were confirmed using a num-
ber oftest procedures.
Table 1 shows the body weight and selected
organ effects at four specific time periods. All 25-
day old pups that had been exposed to mothers
treated with TCDD either during gestation
and/or during the nursing period were significan-
tly lighter in weight than the corresponding con-
trols. There was no significant difference bet-
ween the two treated groups. The diminished
body weight also was seen in rats at 39 days. At
59 days and 145 days of age, rats which had only
postnatal exposure did not have body weights
which varied significantly from controls. Rats ex-
posed pre- and postnatally never attained body
weights equivalent to controls. Ratios of thymus
weight to body weight parallel the changes in
body weight in both experimental groups at 25
and 39 days of age. This effect persisted in rats
that had received pre- and postnatal exposure
when evaluated at 59 and 145 days of age.
Depressed ratios of spleen to body weight were
also found.
Evaluations of in vitro immune capabilities of
spleen and thymus lymphoid cells were per-
formed. In these studies, cell suspensions from
spleen and thymus were cultured in the presence
of specific mitogens. The mitogens used were
phytohemaglutinin (PHA) and concanavilin A
(Con A); both specifically stimulate T-cells (cell-
mediated response). Cells are cultured in the
presence of these mitogens for 72 hr; tritiated
thymidine is then added and the cells are cultured
for an additional 18 hr. At the end of this time,
the cold trichloroacetic acid (TCA)-precipitable
material from the cultures was harvested and
tritium incorporation determined by liquid scin-
tillation spectrometry. The index illustrated in
Figure 1 was derived by dividing the counts per
minute (cpm) in TCA-insoluble material from
cells exposed to the mitogen by the cpm in TCA-
insoluble material from cells not exposed to the
mitogen. The clear bar represents the controls,
the stipled bar represents the rats exposed post-
natally, the solid bar depicts rats that have
received both pre- and postnatal TCDD exposure.
Current immunologic dogma suggests that the
response to PHA is primarily observed with
mature T-cells (24). This would account for the
greater PHA stimulation seen with spleen cells
when compared to thymus cells. Both treatment
groups showed a diminished response of spleen
cells to PHA at 25 days and 59 days of age. In ad-
dition, the response at 59 days showed a
significant difference between the two treated
groups.
The PHA-treated thymus cells only showed a
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TCDDexposure
Controls
Postnatal
Prenatal and
postnatal
Body wt,
mean
40.89
45.14
20.26
33.30
24.46
30.66
SE
1.14
2.35
2.04'
0.59a
2.45a
1.41"
Thymus/body wt
ratio
3.88+ 0.09
3.13 + 0.13
1.86 ± 0.11a
1.76 ± 0.12a
1.91 ± 0.15a
1.47 ± 0.13,
Spleen/body wt
ratio
3.97 + 0.06
3.92 + 0.03
5.67 ± 0.35a
3.94 ± 0.09
7.04 + 0.82a
4.40 + 0 09-b
39 F 6 Controls
F 6 Postnatal
F 6 Prenatal and
postnatal
59 M 6 Controls
M 6 Postnatal
M 6 Prenatal and
postnatal
145 F 14 Controls
F 16 Postnatal
F 12 Prenatal and
postnatal
ap<0.01 vs. controls.
bp<0.01, prenatal/postnatal vs. postnatal.
'p<0.05, prenatal/postnatal vs. postnatal.
"p<0.05 vs. controls.
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FIGURE 1. Response of isolated spleen and thymus cells from
TCDD-exposed animals to mitogenic stimulation: (open
bars) non-exposed animals; (stipled bars) animals exposed
postnatally via maternal dosing on days 0, 7, and 14; (solid
bars) animals exposed pre- and postnatally via maternal dos-
ing on gestational day 18 and on days 0, 7, and 14.
diminished response in the pre- and postnatally
treated rats at 59 days of age. The relative
unresponsiveness of thymus cells to PHA was
quite apparent.
Concanavilin A is more likely to stimulate the
immature T-cells; therefore, a greater stimula-
tion in cells from the thymus is expected (24).
Although somewhat unresponsive, spleen cell
stimulation by Con A was reduced at the 25 and
59 day time period. Similar results were observed
in the thymus cells at both time periods.
An in vivo measure of cellular immune
capabilities is depicted in Figure 2. The method-
evaluated the ability of rats to develop a delayed
hypersensitivity reaction. In this experiment, the
sensitizing agent was oxazolone. Rats were sen-
sitized by painting the ears with oxazolone
dissolved in ethyl alcohol; 10 days later a stan-
dardized dose of tritiated thymidine was ad-
ministered intraperitoneally. At 24 hr after the
thymidine injection, oxazolone in oliver oil was
painted on one ear. One day later, the rat was
sacrificed and a standard tissue plug taken from
the ear at the site of oxazolone administration.
This plug was digested and radioactivity recor-
ded using a liquid scintillation counter. The un-
treated ear was handled in a similar manner and
served as a control. A ratio was derived from
the degree ofradioactivity found in the oxazolone
ear versus the untreated ear. The theory behind
the test is that, in response to oxazolone ap-
plication to the ear, presensitized immunocom-
petent cells migrate to the area; these cells also
stimulate a macrophage aggregation. The macro-
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Age,
days
25
No. of
Sex rats
F 12
M 6
F 6
M 6
F 6
M 6
89.31
69.84
57.87
191.98
175.97
86.34
178.14
173.81
74.58
1.37
3.42"
4.81a
8.91
5.52
16.74a.
2.02
2.01
13.80ab
3.40 + 0.14
2.09 ± 0.12a
1.79 ±0.19
2.01 ± 0.07
1.86 ± 0.06
1.25 ±0.19d
1.11 ± 0.03
1.00 ± 0.03
0.41 +0.08
3.15 + 0.20
3.33 +0.49
5.39+0.49a""
2.62 0.14
2.68 ± 0.08
3.30 + 0.54
2.42 + 0.04
2.55 + 0.06
2.71 + 0.12
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FIGURE 2. Delayed hypersensitivity responses of TCDD-
exposed animals to the contact sensitizing agent oxazolone:
(open) bars represent nonexposed animals; (shaded bars)
animals exposed postnatally via maternal dosing on days 0,
7, and 14; (crosshatched bars) animals exposed pre- and
postnatally via maternal dosing on gestational day 18 and on
days 0, 7, and 14.
phages contain the thymidine label which was in-
corporated during their formation in bone mar-
row. The experiments clearly showed a dimin-
ished delayed hypersensitivity reaction in the
treated rats at all the time periods evaluated.
Most striking was the persistence of cellular im-
mune depression through the 145th day.
Figure 3 illustrates serum antibody of control
and TCDD-treated rats to the antigen, bovine
gammaglobulin (BGG). Serum antibody is a B-cell
expression, but with this antigen is dependent on
competent T-cell interaction. There was no
statistical difference in response of the treated
versus the controls to a primary and secondary
injection ofBGG.
In summary, the data show suppression in cell-
mediated immune response in offspring of
animals which had received TCDD. The im-
munosuppression persisted thorugh 145 days (the
last period tested). The depression of the cellular
immune (T-cell) system is somewhat selective,
given that a normal response to BGG was ob-
served.
Interpretation of Immunologic Data
There are a number of environmental,
physiologic, and pathologic conditions that in-
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FIGURE 3. Antibody response of TCDD-exposed animals,
showing (A) primary and secondary response to injection
with bovine gamma globulin and (B) response of animals in-
jected with bovine gamma globulin two consecutive weeks:
(-) nonexposed animals; (e) animals exposed to TCDD
postnatally via maternal dosing on days 0, 7, and 14; (A)
animals exposed to TCDD pre- and postnatally via maternal
dosing on gestation day 18and on days 0, 7, and 14.
fluence immune response. These factors need to
be considered when evaluating immune response
data. Such evaluation may allow a determination
as to whether a suppressed state is secondary to
other toxic effects. Several of these conditions
merit discussion.
Adrenal glucocorticoid hormones induce lym-
phopenia and lymphoid depletion particularly in
the thymus (25-27). Such an effect can be
produced by endogenous or exogenous adrenal
hormone. To evaluate an immune suppression
mediated by corticosteroids, one should evaluate
adrenal weight and morphology; the
measurement of serum corticosteroid levels or
the use of adrenalectomized animals would afford
a more precise evaluation.
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munosuppression has been produced in animals
that are diminished in size is difficult. It has been
clearly established that animals without a func-
tional thymus develop a runted appearance and
are deficient in cell mediated immunity (28-30).
Similarly, general toxicity during the nursing
period can produce diminished weight gain and a
runted appearance. Decreased food consumption
or impaired food utilization will also produce a
small or runted individual. It has been shown that
malnutrition, either on a net energy basis or from
a selective protein deficiency, causes a
diminished immune capability (31-33). Ascribing
a runting condition to either a cause or effect is a
perilous venture!
Species variation in ontogenesis of the immune
response exists from the standpoint of whether it
is a prepartum or largely postpartum
phenomenon (34). In the mouse and rat, this
system is being developed during the very late
prenatal and neonatal period. In the guinea pig,
by contrast, a well-functioning immune system is
present at birth; a similar circumstance is seen in
man. In species where criticalmaturationalevents
occur subsequent to parturition, a number of
environmental factors may have a deleterious im-
pact. A result produced in this circumstance may
not extrapolate to those species in which
maturation occurs within the relatively "protec-
ted" environment of the placenta. Phar-
makokinetic properties also bear on this issue. If
susceptibility to chemical insult during a specific
period exists, the consequence of exposure may
not become manifest in an in utero environment
due to maternal distribution; however, a high
dose level could be realized during the neonatal
period. TCDD shows such a dose related cir-
cumstance to some degree in that there is
significant secretion of TCDD from maternal
stores in milk. Thus, neonatal TCDD exposure is
greater than is fetal exposure. Such factors, of
course can be evaluated through appropriate
cross-fostering techniques.
A final point relative to interpretation of im-
mune function results is selectivity of im-
munosuppressive effects. The TCDD data clearly
shows a suppression of the cellular immune
capabilities. Humoral (B-cell) function seems
unimpaired. Preliminary results reported with
methylmercury suggest, according to Spyker
(15), impairment of B-cell, not T-cell function.
Furthermore, the TCDD studies indicate that
there may be a selectivity in the suppression of
cellular immunity given that response to bovine
gammaglobulin, a T-dependent response, was not
diminished.
Methodology
Species Selection
The rat and mouse are recommended because:
(1) these are species in which teratology data may
be available from which one could determine
dose, and (2) many classical immunology methods
have been developed in mice and, to a lesser ex-
tent, the rat. There is, however, the possible
problem of extrapolation to man of data obtained
from these species due to the postnatal
maturation ofthe immune system.
LitterManipulations
The number of pups within a litter needs to be
standardized at birth to eliminate variables
associated with nutritional effects. Cross-
fostering techniques need to be considered in ex-
periments which confirm initial results and deter-
mine whether the immunosuppressive effect is
due to in utero exposure or exposure during the
nursing period; i.e., milk, maternal behavior, etc.
Age ofTesting
Initial assessment of the immune response
shortly after the time of weaning would seem
most appropriate.
Immunology Test Methods
Methods suggested are generally ones that are
accepted by immunologists, and, most im-
portantly, are well within the capabilities of
many laboratories.
Production of Serum Antibodies: By selection
of specific antigens, one can determine the
capabilities ofboth B and T-lymphocytes.
Lipopolysaccharide (LPS), a commercially
available product, is an antigen to which serum
antibodies may be raised through a mechanism
dependent only upon B-cell capabilities (35,36).
Alternatively, sheep red blood cells (SRBC) may
be used as the antigen to elicit a serum antibody
at a normal level only if there are T-cells to
initially interact with this antigen and B-cells to
subsequently produce the serum antibody
(37-39). Serum antibodies to these antigens can
be quantified using hemagglutination techniques.
In a minimal experimental design, one should
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ot the LPS method, since a response to SRBCs,
being a T- and B-cell-dependent phenomenon, is a
more inclusive method.
Delayed Hypersensitivity: This in vivo method
is a most adequate means of evaluating cellular
immune capabilities. In addition to evaluating the
responsiveness of particular T-cell lymphocytes,
it also gives some indication of the ability of the
animal to marshall other factors associated with
the hypersensitivity reaction, such as
chemotaxis, macrophage infiltration, and ac-
cumulation. A specific test we recommend is the
measurement of specific migration of
radiolabeled cells to a site of antigenic challenge
(40). The sensitizing agent we would currently
suggest is mycobacterium through use of Com-
plete Freunds Adjuvant. Challenge would then
be carried out with purified protein derivative.
Response to Mitogen Stimulatiow With this in
vitro method, one exposes cultures cells to a sub-
stance known to stimulate mitotic activity in
select populations of lymphoid cells. The degree
of stimulation is evaluated through the in-
corporation of radiolabeled thymidine into DNA
by these cells during replication. There are
mitogens that selectively stimulate the cellular
immune (T-cell), or humoral immune (B-cell),
components. Phytohemaglutinin and con-
canavilin A are T-cell stimulators, while LPS
seems to stimulate only B-cells (41). We routinely
set up cell cultures from thymus as well as spleen.
We then have a good likelihood of getting an in-
dication of the nature of the immune defect; i.e.,
thymus has a different population of T-cells than
does spleen, where mature forms of T-
lymphocytes are found as are cells that will
respond to a B-cell mitogen.
At the beginning of this presentation, it was
stated that all chemicals should not be evaluated
for possible effects on the developing immune
system; it is felt there are a number of situations
which would suggest that this system be
assessed. Chemicals which depress immune func-
tion in adults should be evaluated in the
fetus/neonate. Postnatal studies which result in
runting syndrome at time of weaning or through
a wasting disease later in life suggest that the im-
mune response may be impaired. Finally, routine
teratology procedures need to be revised to in-
clude an evaluation of major lymphoid organs,
i.e., thymus and spleen. Such an examination
should include organ weights and histologic
examination. These procedures can be readily in-
corporated into any standard teratology screen;
histologic evaluation can be done most ex-
pediently through multiple imbedding of tissues.
If there is indication of diminished maturation of
these systems, one should consider subsequent
experiments that specifically assess immune
response.
The authors are grateful to Mrs. L. D. Lawson for valuable
technical assistance and to Dr. J. K. Haseman for statistical
analyses.
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